The Global Market for Therapeutic and Diagnostic Products for Diabetes Is Valued at $38 Billion in 2010. This Market Is Expected to Grow at A Compound Annual Growth Rate (Cagr) of 6.1% to Reach $51.2 Billion in 2015.
Insulin Products, Including Administration Devices, Are worth An Estimated $16.4 Billion in 2010. This Sector Is Expected to Reach $22 Billion in 2015, A 6.1% Compound Annual Growth Rate (Cagr).
Oral Hypoglycemic Drugs Are Expected to Achieve The Highest Compound Annual Growth Rate (Cagr) of 8%, Increasing from $10.3 Billion in 2010 to $15.1 Billion in 2015.

Introduction

Study Goals and Objectives

The Aim of This Report Is to Provide Detailed Market, Technology and Industry Analyses to Help Readers Quantify and Qualify The Market for Prescription Generic Drugs Used in The Treatment of Diabetes and Devices and Instruments Used for Diagnosis and Monitoring of Diabetes. Important Trends Are Identified and Sales Forecasts by Product Categories and Major Country Markets Are Provided through 2015; These Are Based on Epidemiological Data and Projections, plus Information on R&D Trends and Differential Market Potential on A Country-by-Country Basis. Healthcare Policies, Demographics, and The Wider Economic Environment Are Also Taken into Account.

Reasons for Doing The Study

IT Is Widely Recognized That The Prevalence of The Commonest Type of Diabetes Mellitus, Type 2, Is Now Reaching Epidemic Proportions All over The World. Cases of Type 1 Dm Are Also on The Increase, Although to A Less Spectacular Degree. These Trends Are of Great Concern, Not Only to The Individuals Concerned, but to Governments and Providers of Healthcare, Because The Economic Consequences of Diabetes Are Vast, as They Involve Not Only The Direct Burden of Managing The Disease but Also The Common and Often Catastrophic Complications Including Cardiovascular Disease, Peripheral Neuropathy and Blindness.

Thus The Prompt Diagnosis and Effective Treatment of Diabetes Are Essential, Not Optional, Priorities for Governments and Healthcare Agencies. One Consequence Is That The Already Large Market for Diabetes Monitoring and Treatment Will Certainly Grow in Line with Increasing Incidence and with Improvements in Diagnosis. Thus Diabetes Is of Great Commercial Significance to The Suppliers of Drugs Used in Treatment and Devices Needed for Monitoring.

Among The Information Needs of Companies in This Field Is Accurate and up-to-Date Assessment of The Current Extent of The Diabetes Epidemic, Its Likely Evolution over The next 5 Years, and The Impact of Drugs and Technical Developments Now in The Pipeline.

Scope of Report

This Report Discusses The Implications of The above-Mentioned Trends, in The Context of The Current Size and Growth of The Diabetes Market, Both in Global Terms and Analyzed by The Most Important National Markets. Companies in The Relevant Pharmaceutical and Medical Industries Are Discussed, with Profiles of The Leaders and An Update on M&A Activity. Five-Year Global Sales Forecasts Are Provided for Main Drug and Device Categories, and Breakdowns Are Provided for Several National Markets.

Market Analysis and Forecasts

Market Figures Are Based on Revenues at The Manufacturer Level and Are Projected at 2010-Dollar Value without Attempting to Predict The Effect of Inflation/Deflation.

Therapeutic Categories Quantified and Forecast Include Insulins and Oral Hypoglycemic Agents, and Devices Including Blood Glucose Monitors and Accessories.

Methodology

Primary Research Includes Interviews with Leading Individuals in Relevant Companies and Medical Associations; Primary Sources of Published Data Include Epidemiological and Economic Studies, Company Annual Reports, Sec Filings, and Government Publications. Secondary Sources Consist of Literature Searches, Industry Journals, and Other Commercial Publications. Data for Market Estimates and Forecasts Are Pooled from A Range of Sources, Critically Assessed by BCC.

Intended Audience

This Report Is Designed to Satisfy The Information Needs of A Wide Variety of Individuals Involved in The Diabetes Marketplace, Including Company Senior Management Executives Seeking to Base Their Strategic Decisions on The Best Available Information on Market Forces and Trends. However, IT Is Also Aimed at Managers and Executives in Marketing, Research, Planning, and Sales Departments Who Need Readable, Comprehensive and up-to-Date Background on The Marketplace in Which They Are Operating.

Information Sources

Sources of Information Included Marketing Strategists, Industry Executives, Government and Professional Agencies, and Surveys of Physicians. Company Annual Reports and Sec Filings, Journal Articles, and Data from Healthcare Institutions Were Also Mined, as Well as Publications of Relevant Associations Such as The International Diabetes Federation and The American and British Diabetic Associations.

Chapter- 1: Introduction -- Complimentary
- Study Goals and Objectives
- Reasons for Doing The Study
- Scope of Report
- Market Analyses and Forecasts
- Methodology
- Intended Audience
- Information Sources
- Analyst Credentials
- Related Reports
- BCC Online Services
- Disclaimer 4
Chapter-2: Summary
- The Diabetes Market
- Leading Companies
- Summary Table Diabetes Market Breakdown by Product Groups, through 2015 ($ Billions)
- Summary Figure Diabetes Market Evolution by Product Group, 2010 and 2015 ($ Billions) 6
Chapter-3: Overview
- Diabetes Basics
- A Growing Market
- Drug Treatment of Diabetes
- Insulin
- Oral Antidiabetic Drugs
- The Pharmaceutical Diabetes Market
- Insulin Administration Devices
- Medical Devices for Diabetes
- Table 1 Total Diabetes Market ($)
- Regional Segmentation
- Table 2 Adult Diabetes Market, by Region (Millions/%)
- Market Growth
- The Diabetes Industry
- Pharmaceutical Companies
- Medical Device Companies 12
Chapter-4: about Diabetes
- What Is Diabetes?
- Blood Sugar Regulation
- Insulin
- Type 1 Diabetes
- Type 2 Diabetes
- Gestational Diabetes
- Obesity-Related Type 2 Diabetes in Children
- Mature-Onset Diabetes of The Young (Mody)
- Other Diabetic States
- Diagnosis
- Glucose Tests
- Official Criteria
- Differential Diagnosis
- Type 1 Diabetes
- Type 2 Diabetes
- Current Treatment
- Type 1 Diabetes
- Table 3 Main Brands and Types of Insulin
- Type 2 Diabetes
- Sulphonylureas
- Biguanides
- Alpha-Glucosidase Inhibitors
- Glitazones (Thiazolidinediones)
- Prandial Glucose Regulators
- Incretin Mimetics
- Dpp-4 Inhibitors
- Table 4 Oral Diabetes Treatments
- Diet
- Future Treatment Approaches
- Monitoring Diabetes
- Blood Sugar Control
- The Diabetes Control and Complications Trial
- Glycated Haemoglobin (Hba1c)
- Fructosamine
- Prevalence of Diabetes
- Table 5 Prevalence of Diabetes by Region, 2010 and 2030 (Population Aged 20 to 79)
- Type 1
- Type 2
- Diabetic Complications
- Retinopathy
- Neuropathy
- Nephropathy
- Prevalence by Region
- Table 6 Prevalence Range of Diabetic Complications by Region, 2006
- Increased Mortality Risk
- Metabolic Syndrome 34
Chapter-5: Diabetes Therapies
- Insulin
- History
- Bovine and Porcine Insulin
- Humanized Insulin
- Companies Supplying Insulin
- Eli Lilly
- Sanofi Aventis
- Novo Nordisk
- Some Other Suppliers
- Wockhardt Limited: India
- Bioconb: India
- Shreya Life Sciences: India
- Diosynth: The Netherlands
- Table 7 Major Brands of Insulin
- Table 7 (Continued)
- Insulin Delivery
- Syringes
- Insulin Syringe Manufacturers
- Becton Dickinson
- Owen Mumford
- Terumo
- B. Braun
- Pens
- Table 8 Insulin Pens
- Manufacturers of Insulin Pens
- Novo Nordisk
- Owen Mumford
- Other Makers
- Injectors
- Injector Manufacturers
- Activa Brand Products
- Antares Pharma
- Bioject
- Medicool, Inc
- Owen Mumford
- Palco Labs, Inc
- Rosch Ag Medizintechnik
- Inhaled Insulin
- Other Insulin Delivery Approaches
- Oral-Lyn
- Oramed
- Medingo Micro-Pump Patch
- Insulin Pumps
- The Infusion Set
- Candidates for Pump Therapy
- Companies Supplying Insulin Pumps
- Animas Corporation
- Sooil Development Company
- Medtronic Minimed
- Nipro Diabetes Systems
- Roche Disetronic
- Smiths Medical
- Insulet
- Table 9 Insulin Pumps
- Problems with Pumps or Users?
- Problems with Pumps or Users? (Continued) 55
Chapter-6: Oral Hypoglycemic Drugs
- Sulfonylureas
- Table 10 Sulfonylureas
- Biguanides
- Alpha-Glucosidase Inhibitor
- Glitazones
- Prandial Glucose Regulators
- Glp-1 Analogs; Also Known as Incretin Mimetics
- Amylin Mimetic
- Table 11 Oral Hypoglycemics
- New Products Now in R&D
- Dutogliptin
- Taspoglutide
- Byetta Lar
- Lixisenatide 60
Chapter-7: Diagnosis and Monitoring
- The Role of Self-Monitoring
- Smbg Frequency
- Blood Glucose Monitoring Devices: Suppliers and Products
- Lancets
- Table 12 International Suppliers of Blood Lancets
- Blood Sampling Devices
- Bayer Diagnostics
- Becton Dickinson
- Cell Robotics
- Lifescan
- Roche Diagnostics
- Blood Glucose Monitors
- 77 Elektronica Kft
- Abbott Laboratories
- Acon Laboratories Inc
- Agamatrix Inc
- Apex Biotechnology Corp
- Arkray USA
- Aventir Biotech Llc
- Bayer Corporation
- Belbiosens
- Diagnostic Devices Inc
- Eumed Biotechnology Co. Ltd
- Hmd Bio Medical
- Glucoplus Inc
- Health & Life Co
- Hemocue Ab
- Home Diagnostics Inc
- Hypoguard
- I-Sens Inc
- Lifescan Inc
- Medtronic Minimed
- Menarini Diagnostics
- National Diagnostic Products
- Novabiomedical Corporation
- Roche
- Taidoc Technology Corporation
- US Diagnostics Inc
- Glucose Meter Accuracy
- New Developments in Glucose Testing
- Continuous Glucose Monitoring (Cgm)
- Continuous Glucose Monitoring ... (Continued)
- Reimbursement
- Non-Invasive Monitoring
- Non-Invasive Monitoring (Continued)
- Non-Invasive Monitoring (Continued)
- Non-Invasive Monitoring (Continued)
- Non-Invasive Monitoring (Continued)
- Table 13 Selected Companies Developing Non-Invasive Glucose Monitoring
- Table 13 (Continued)
- Artificial Pancreas
- Roche
- Abbott
- Novo Nordisk/Lifescan
- Other Testing Approaches
- Haemoglobin A1c
- Hemoglobin A1c Meters
- Hemoglobin A1c Kits
- Software Aids to Diabetes Monitoring
- Aida on-Line
- Bayer Care: Blood Sugar Log
- Body Sigma
- Dailyrating
- Diabetease
- Diabetes Assistant
- Diabetes Homecare Center
- Ecivon
- Healthengage Diabetes
- Lifeclinic
- Plasmaglucose
- Symcare 89
Chapter-8: The Diabetes Market
- Market Components
- Size
- Table 14 Global Diabetes Market 2010 ($)
- Growth
- Regional Segmentation
- Table 15 Regional Segmentation of Diabetes Universe, 2010 and 2030 (Millions/%)
- National Markets
- North America
- Table 16 U.S.: Diabetes Market, through 2015 ($ Millions)
- Table 17 Canada: Diabetes Market, through 2015 ($ Millions)
- South and Central America
- Table 18 Argentina: Diabetes Market, through 2015 ($ Millions)
- Table 19 Brazil: Diabetes Market, through 2015 ($ Millions)
- Table 20 Mexico: Diabetes Market, through 2015 ($ Millions)
- Europe
- Table 21 Belgium: Diabetes Market, through 2015 ($ Millions)
- Table 22 Denmark: Diabetes Market, through 2015 ($ Millions)
- Table 23 France: Diabetes Market, through 2015 ($ Millions)
- Table 24 Germany: Diabetes Market, through 2015 ($ Millions)
- Table 25 Italy: Diabetes Market, through 2015 ($ Millions)
- Table 26 Netherlands: Diabetes Market, through 2015 ($ Millions)
- Table 27 Norway: Diabetes Market, through 2015 ($ Millions)
- Table 28 Portugal: Diabetes Market, through 2015 ($ Millions)
- Table 29 Russia: Diabetes Market, through 2015 ($ Millions)
- Table 30 Spain: Diabetes Market, through 2015 ($ Millions)
- Table 31 Sweden: Diabetes Market, through 2015 ($ Millions)
- Table 32 United Kingdom: Diabetes Market, through 2015 ($ Millions)
- Table 33 European Union: Diabetes Market, through 2015 ($ Millions)
- Western Pacific
- Table 34 Australia: Diabetes Market, through 2015 ($ Millions)
- Table 35 China: Diabetes Market, through 2015 ($ Millions)
- Table 36 Japan: Diabetes Market, through 2015 ($ Millions)
- Table 37 South Korea: Diabetes Market, through 2015 ($ Millions)
- Table 38 Taiwan: Diabetes Market, through 2015 ($ Millions)
- South-East Asia
- Table 39 India: Diabetes Market, through 2015 ($ Millions)
- Market Analysis by Product Category
- Monitoring Products
- Major Suppliers
- Table 40 Leading Companies of Glucose Monitoring Products, 2009 ($ Millions/%)
- Insulins and Insulin Delivery Devices
- Major Suppliers
- Table 41 Global Sales of Leading Insulin Products, 2009 ($ Millions)
- Insulin Pumps
- Table 42 Global Insulin Pump Market, by Region, through 2015 ($ Millions)
- Other Antidiabetic Drugs
- Major Suppliers
- Table 43 Sales of Other Antidiabetic Products, 2009 ($ Millions)
- Trends 106
Chapter-9: New Approaches to The Management of Diabetes
- Alternatives to Insulin
- Immunotherapy
- Transplantation
- Cell and Stem Cell Therapies
- Gene Therapy
- Gene Therapy Approaches for Expressing Insulin
- Gene Therapy Approaches for Immunomodulation
- Gene Therapy Approaches for Cell-Based Therapies
Chapter-10: Company Profiles
- Leading Companies
- Abbott Laboratories
- Overview
- Diabetes Products
- Abbott Diabetes Care, Inc
- Bayer
- Overview
- Diabetes Products
- Becton Dickinson
- Overview
- Diabetes Products
- Insulin Injection Devices
- Bristol-Myers Squibb
- Overview
- Problems with Generics
- Diabetes Products
- Eli Lilly and Company
- Overview
- Diabetes Products
- Pipeline
- Glaxo Smithkline
- Overview
- Diabetes Products
- Pipeline
- Table 44 Diabetes Products in Gsk Pipeline
- Johnson & Johnson
- Overview
- Diabetes Products
- Medtronic
- Overview
- Diabetes Products
- Pipeline
- Merck Kgaa
- Overview
- Diabetes Product
- Novartis International Ag
- Overview
- Diabetes Products
- Research
- Novo Nordisk A/S
- Overview
- Diabetes Products
- Pharmaceuticals
- Injection Devices
- Pipeline
- Roche
- Overview
- Diabetes Products
- Blood Glucose Monitoring Systems
- Diabetes Data Management
- Insulin Pump Systems
- Lancet Devices
- Other
- Pipeline
- Sanofi-Aventis
- Overview
- Diabetes Products
- Takeda
- Overview
- Pipeline
- Table 45 Diabetes Products in Development by Takeda
- Other Companies
- 77 Elektronika Co., Ltd
- Agamatrix, Inc
- Animas Corporation
- Debiotech S.A
- Inlight Solutions, Inc
- Lifescan, Inc
- A. Menarini Diagnostics S.R.L
- Nipro Corporation
- Owen Mumford Ltd
- Palco Labs, Inc
- Terumo Corp
- Appendix 7 $340
- Appendix
- Table 46 Glossary

Pharmaceutical Market Research

Diabetes Therapies & Diagnostics